Cellular senescence occurred widespread to multiple selective sites in the fetal tissues and organs of mice

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 12, 2014, Pages 965-975

  Zhang, Kexiong ^a   Chen, Chengshu ^a   Liu, Yingying ^a   Chen, Hao ^a   Liu, Jun Ping ^a,b,c  

^a HANGZHOU NORMAL UNIVERSITY   (China)

^b MONASH UNIVERSITY   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Bone; Cell senescence; Embryonic development; Ossification; Placenta; Skeletal development

Indexed keywords

BETA GALACTOSIDASE; KI 67 ANTIGEN; PROTEIN P16; PROTEIN P19; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; BRAIN; CARTILAGE; CARTILAGE CELL; CELL AGING; CELL CYCLE CHECKPOINT; CELL POPULATION; CHOROID PLEXUS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EAR; EMBRYO; EMBRYO DEVELOPMENT; ENDOLYMPHATIC SAC; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; FETUS (ANATOMY); GENE EXPRESSION; GIANT CELL; IMMUNOHISTOCHEMISTRY; INNER EAR; INTERDIGITAL WEB; JAW; LIMB; LONG BONE; MANDIBLE; MATERNAL BLOOD; MAXILLA; MOUSE; MOUTH; NONHUMAN; ORGAN; OSSIFICATION; PLACENTA; PREGNANCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENESCENCE; SIGNAL TRANSDUCTION; SKULL; STAINING; STOMACH; TAIL; TISSUE GROWTH; TROPHOBLAST;

EID: 84912524518     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12328     Document Type: Article

References (75)

1. Edney EB, Gill RW. Evolution of senescence and specific longevity. Nature 1968; 220: 281-2.
2. Holliday R. Senescence of human cells in culture. Nature 1973; 242: 332.
3. Shapiro BL, Lam LF, Fast LH. Premature senescence in cultured skin fibroblasts from subjects with cystic fibrosis. Science 1979; 203: 1251-3.
4. Mueller SN, Rosen EM, Levine EM. Cellular senescence in a cloned strain of bovine fetal aortic endothelial cells. Science 1980; 207: 889-91.
5. Gibson GE, Peterson C, Jenden DJ. Brain acetylcholine synthesis declines with senescence. Science 1981; 213: 674-6.
6. Goldstein S. Replicative senescence: The human fibroblast comes of age. Science 1990; 249: 1129-33.
7. Yu GL, Bradley JD, Attardi LD, Blackburn EH. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 1990; 344: 126-32.
8. Hughes KA, Charlesworth B. A genetic analysis of senescence in Drosophila. Nature 1994; 367: 64-6.
9. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp. Cell Res. 1961; 25: 585-621.
10. Liu JP, Nicholls C, Chen SM, Li H, Tao ZZ. Strategies of treating cancer by cytokine regulation of chromosome end remodelling. Clin. Exp. Pharmacol. Physiol. 2010; 37: 88-92.
11. Bayne S, Jones ME, Li H, Pinto AR, Simpson ER, Liu JP. Estrogen deficiency leads to telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice. Cell Res. 2008; 18: 1141-50.
12. Li H, Liu JP. Signaling on telomerase: A master switch in cell aging and immortalization. Biogerontology 2002; 3: 107-16.
13. Liu JP. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB J. 1999; 13: 2091-104.
14. Kaplon J, Zheng L, Meissl K et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 2013; 498: 109-12.
15. Di Micco R, Fumagalli M, Cicalese A et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444: 638-42.
16. Bartkova J, Rezaei N, Liontos M et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444: 633-7.
17. Jiang P, Du W, Mancuso A, Wellen KE, Yang X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 2013; 493: 689-93.
18. Kuwahara M, Suzuki J, Tofukuji S et al. The Menin-Bach2 axis is critical for regulating CD4 T-cell senescence and cytokine homeostasis. Nat. Commun. 2014; 5: 3555.
19. Di Mitri D, Toso A, Chen JJ et al. Tumour-infiltrating Gr-1 myeloid cells antagonize senescence in cancer. Nature 2014; 515: 134-7.
20. Dorr JR, Yu Y, Milanovic M et al. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy. Nature 2013; 501: 421-5.
21. Acosta JC, Banito A, Wuestefeld T et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 2013; 15: 978-90.
22. Liu F, Wu S, Ren H, Gu J. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat. Cell Biol. 2011; 13: 254-62.
23. Chien Y, Scuoppo C, Wang X et al. Control of the senescence-associated secretory phenotype by NF-kappaB promotes senescence and enhances chemosensitivity. Genes Dev. 2011; 25: 2125-36.
24. Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl Acad. Sci. USA 2009; 106: 17031-6.
25. Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM. Cellular senescence in aging primates. Science 2006; 311: 1257.
26. Baker DJ, Perez-Terzic C, Jin F et al. Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nat. Cell Biol. 2008; 10: 825-36.
27. Jeyapalan JC, Ferreira M, Sedivy JM, Herbig U. Accumulation of senescent cells in mitotic tissue of aging primates. Mech. Ageing Dev. 2007; 128: 36-44.
28. Ohtani N, Imamura Y, Yamakoshi K et al. Visualizing the dynamics of p21(Waf1/Cip1) cyclin-dependent kinase inhibitor expression in living animals. Proc. Natl Acad. Sci. USA 2007; 104: 15034-9.
29. Ohtani N, Yamakoshi K, Takahashi A, Hara E. Real-time in vivo imaging of p16gene expression: A new approach to study senescence stress signaling in living animals. Cell Div 2010; 5: 1.
30. Waaijer ME, Parish WE, Strongitharm BH et al. The number of p16INK4a positive cells in human skin reflects biological age. Aging Cell 2012; 11: 722-5.
31. Baker DJ, Wijshake T, Tchkonia T et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479: 232-6.
32. Sousa-Victor P, Gutarra S, Garcia-Prat L et al. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 2014; 506: 316-21.
33. Liu JP. Molecular mechanisms of ageing and related diseases. Clin. Exp. Pharmacol. Physiol. 2014; 41: 445-58.
34. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88: 593-602.
35. Guerra C, Collado M, Navas C et al. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 2011; 19: 728-39.
36. Campaner S, Doni M, Hydbring P et al. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat. Cell Biol. 2010; 12: 54-9; sup. pp. 1-14.
37. Kang TW, Yevsa T, Woller N et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011; 479: 547-51.
38. Yoshimoto S, Loo TM, Atarashi K et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499: 97-101.
39. Kaplon J, Zheng L, Meissl K et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 2013; 498: 109-12.
40. Jiang P, Du W, Mancuso A, Wellen KE, Yang X. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 2013; 493: 689-93.
41. Braumuller H, Wieder T, Brenner E et al. T-helper-1-cell cytokines drive cancer into senescence. Nature 2013; 494: 361-5.
42. Kang TW, Yevsa T, Woller N et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 2011; 479: 547-51.
43. Lin HK, Chen Z, Wang G et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 2010; 464: 374-9.
44. Krizhanovsky V, Yon M, Dickins RA et al. Senescence of activated stellate cells limits liver fibrosis. Cell 2008; 134: 657-67.
45. Sagiv A, Biran A, Yon M, Simon J, Lowe SW, Krizhanovsky V. Granule exocytosis mediates immune surveillance of senescent cells. Oncogene 2013; 32: 1971-7.
46. Fitzner B, Muller S, Walther M et al. Senescence determines the fate of activated rat pancreatic stellate cells. J. Cell Mol. Med. 2012; 16: 2620-30.
47. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat. Cell Biol. 2010; 12: 676-85.
48. Kim KH, Chen CC, Monzon RI, Lau LF. Matricellular protein CCN1 promotes regression of liver fibrosis through induction of cellular senescence in hepatic myofibroblasts. Mol. Cell. Biol. 2013; 33: 2078-90.
49. Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 1995; 92: 9363-7.
50. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-beta gal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 2009; 4: 1798-806.
51. Lee BY, Han JA, Im JS et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 2006; 5: 187-95.
52. Kurz DJ, Decary S, Hong Y, Erusalimsky JD. Senescence-associated β-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J. Cell Sci. 2000; 113: 3613-22.
53. Muñoz-Espín D, Cañamero M, Maraver A et al. programmed cell senescence during mammalian embryonic development. Cell 2013; 155: 1104-18.
54. Storer M, Mas A, Robert-Moreno A et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 2013; 155: 1119-30.
55. Stewart S, Yi S, Kassabian G, Mayo M, Sank A, Shuler C. Changes in expression of the lysosomal membrane glycoprotein, LAMP-1 in interdigital regions during embryonic mouse limb development, in vivo and in vitro. Anat. Embryol. 2000; 201: 483-90.
56. Karsenty G, Wagner EF. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2002; 2: 389-406.
57. Su N, Du X, Chen L. FGF signaling: its role in bone development and human skeleton diseases. Front Biosci. 2008; 13: 2842-65.
58. Chen L, Deng CX. Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci. 2005; 10: 1961-76.
59. Zhang R, Murakami S, Coustry F, Wang Y, de Crombrugghe B. Constitutive activation of MKK6 in chondrocytes of transgenic mice inhibits proliferation and delays endochondral bone formation. Proc. Natl Acad. Sci. USA 2006; 103: 365-70.
60. Yang J, Qin S, Yi C et al. MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation. FEBS Lett. 2011; 585: 2992-7.
61. Harbo M, Bendix L, Bay-Jensen AC et al. The distribution pattern of critically short telomeres in human osteoarthritic knees. Arthritis. Res. Ther. 2012; 14: R12.
62. Watson ED, Cross JC. Development of structures and transport functions in the mouse placenta. Physiology 2005; 20: 180-93.
63. Adamson SL, Lu Y, Whiteley KJ, Holmyard D, Hemberger M, Pfarrer C, Cross JC. Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta. Dev. Biol. 2002; 250: 358-73.
64. Smith SC, Leung TN, To KF, Baker PN. Apoptosis is a rare event in first trimester placental development. Am. J. Obstet. Gynecol. 2000; 183: 697-9.
65. Rochette PJ, Brash DE. Progressive apoptosis resistance prior to senescence and control by the anti-apoptotic protein BCL-xL. Mech. Ageing Dev. 2008; 129: 207-14.
66. Ryu SJ, Park SC. Targeting major vault protein in senescence-associated apoptosis resistance. Expert Opin. Ther. Targets 2009; 13: 479-84.
67. Kim KM, Kim JM, Yoo YH, Kim JI, Park YC. Cilostazol induces cellular senescence and confers resistance to etoposide-induced apoptosis in articular chondrocytes. Int. J. Mol. Med. 2012; 29: 619-24.
68. Sanders YY, Liu H, Zhang X et al. Histone modifications in senescence-associated resistance to apoptosis by oxidative stress. Redox. Biol. 2013; 1: 8-16.
69. Nelson DM. Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast. Placenta 1996; 17: 387-91.
70. Burton DG, Krizhanovsky V. Physiological and pathological consequences of cellular senescence. Cell. Mol. Life Sci. 2014; 71: 4373-86.
71. Sharp AN, Heazell AE, Baczyk D et al. Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast. PLoS ONE 2014; 9: e87621.
72. Wang YL, Qiu W, Feng HC et al. Immortalization of normal human cytotrophoblast cells by reconstitution of telomeric reverse transcriptase activity. Mol. Hum. Reprod. 2006; 12: 451-60.
73. Dong F, Huang Y, Li W et al. The isolation and characterization of a telomerase immortalized goat trophoblast cell line. Placenta 2013; 34: 1243-50.
74. Wu L, de Bruin A, Saavedra HI, Starovic M et al. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 2003; 421: 942-7.
75. Zhang K, Waxman DJ. Impact of tumor vascularity on responsiveness to antiangiogenesis in a prostate cancer stem cell-derived tumor model. Mol. Cancer Ther. 2013; 12: 787-98.